Rumni orange chewable tablets, # 20

Special Price $18.43 Regular Price $27.00
In stock
SKU
BIDL3179325
368.6 Reward Points will be used to purchase this product

Expiration Date: 05/2027

Russian Pharmacy name:

Рамни апельсин таблетки жевательные, №20

Rumni orange chewable tablets, # 20

Symptoms associated with increased acidity of gastric juice and reflux esophagitis: heartburn, acidic belching, periodic pain in the stomach, a feeling of fullness or heaviness in the epigastric region, dyspepsia (including those caused by an error in the diet, taking medications, alcohol abuse of coffee with nicotine), dyspepsia of pregnant women.

Inside.

Adults and children over 12 years of age: unless otherwise recommended by a doctor, when symptoms appear, chew 1-2 tablets (or keep in the mouth until completely dissolved). If necessary, you can repeat the drug intake after 2 hours.

The maximum daily dose is 11 tablets.

1 tablet contains:

Active ingredients: calcium carbonate - 680 mg, magnesium carbonate (basic magnesium carbonate) - 80 mg;

Excipients: mannitol, povidone (Kollidone 90 F), sucrose, orange flavor, sodium stearyl fumarate, talc.

Severe renal failure

hypercalcemia,

hypophosphatemia,

nephrocalcinosis,

hypersensitivity to the components of the drug,

deficiency of sucrase / isomaltase,

intolerance to fructose,

glucose-galactose malabsorption,

children under 12 years of age.

Trade name of the drug

RamniЃ

International non-proprietary name

Calcium carbonate + Magnesium carbonate

Dosage form

Chewable tablets

Composition

1 tablet contains:

Active ingredients: calcium carbonate - 680 mg, magnesium carbonate (basic magnesium carbonate) - 80 mg;

Excipients: mannitol, povidone (Kollidone 90 F), sucrose, orange flavor, sodium stearyl fumarate, talc.

Description

Round, flat-cylindrical tablets, white or white with a cream shade, with enhanced bevelling, without risks, with the smell of orange. Light marbling and minor inclusions are allowed.

Pharmacotherapeutic group

antacid

ATX code

A02AX

Pharmacodynamics:

RamniЃ contains antacid substances - calcium carbonate and magnesium carbonate, which provide fast and long-lasting neutralization of excess gastric acid hydrochloric acid, thereby providing a protective effect on the gastric mucosa. Achievement of a positive effect within 3-5 minutes is due to the good solubility of the tablets and the high calcium content.

Pharmacokinetics:

As a result of the interaction of RamniЃ with gastric juice, soluble calcium and magnesium salts are formed in the stomach. The level of absorption of calcium and magnesium from these compounds depends on the dose of the drug. The maximum absorption rate is 10% calcium and 15-20% magnesium. Small amounts of absorbed calcium and magnesium are excreted through the kidneys. With impaired renal function, the concentration of calcium and magnesium in plasma may increase. In the intestine, insoluble compounds are formed from soluble salts, which are excreted in the feces.

Indications:

Symptoms associated with increased acidity of gastric juice and reflux esophagitis: heartburn, acidic belching, periodic pain in the stomach, a feeling of fullness or heaviness in the epigastric region, dyspepsia (including those caused by an error in the diet, taking medications, alcohol abuse of coffee with nicotine), dyspepsia of pregnant women.

Contraindications:

Severe renal failure

hypercalcemia,

hypophosphatemia,

nephrocalcinosis,

hypersensitivity to the components of the drug,

deficiency of sucrase / isomaltase,

intolerance to fructose,

glucose-galactose malabsorption,

children under 12 years of age.

Pregnancy and lactation:

When used in recommended doses, the drug does not pose a danger to the fetus or child.

Method of administration and dosage:

Inside.

Adults and children over 12 years of age: unless otherwise recommended by a doctor, when symptoms appear, chew 1-2 tablets (or keep in the mouth until completely dissolved). If necessary, you can repeat the drug intake after 2 hours.

The maximum daily dose is 11 tablets.

Side effects:

If the recommended doses are observed, the drug is well tolerated; nevertheless, in very rare cases, allergic reactions are possible: rash, Quincke's edema, anaphylactic reactions.

Overdose:

Long-term use of the drug in high doses in patients with impaired renal function can cause hypermagnesemia, hypercalcemia, alkalosis, which can manifest as nausea, vomiting, muscle weakness. In this case, the drug should be discontinued and a doctor should be consulted immediately.

Interaction:

A change in the acidity of gastric juice during the use of antacids can lead to a decrease in the rate and degree of absorption of other drugs while taking them; therefore, drugs should be taken 1-2 hours before or after taking antacids.

Antibiotics of the tetracycline series fluoroquinolones cardiac glycosides levothyroxine iron preparations phosphate fluorides - with the simultaneous use of antacids, they reduce the absorption of these drugs.

Thiazide diuretics - when taken simultaneously with antacids, the concentration of calcium in the blood serum should be regularly monitored.

Special instructions:

When prescribing the drug to patients with impaired renal function, the concentration of magnesium, phosphorus and calcium in the blood serum should be regularly monitored.

Patients with impaired renal function are not recommended to take the drug in high doses for a long time.

The use of RamniЃ in high doses may increase the risk of kidney stones.

Direction for patients with diabetes mellitus: 1 tablet of RamniЃ contains 2953 mg sucrose (003 XE).

If the use of the drug is ineffective, you should consult a doctor for advice.

Impact on the ability to drive vehicles. Wed and fur .:

The use of the drug does not affect the ability to perform potentially hazardous activities requiring an increased concentration of attention and speed of psychomotor reactions (driving vehicles, working with moving mechanisms, the work of a dispatcher and an operator).

Release form / dosage:

Chewable tablets.

Packaging:

6 or 10 tablets in a blister strip packaging.

1 or 2 blister packs together with instructions for use are placed in a cardboard box.

Storage conditions:

At a temperature not higher than 25 ? C.

Keep out of the reach of children.

Shelf life:

3 years.

Do not use after the expiration date.

Vacation conditions

Without recipe

Submit your review to Earn 10 Reward Points click here to login

Write Your Own Review
You're reviewing:Rumni orange chewable tablets, # 20

 Job in company (10-20 minutes a day | 400 - 1200 USD)! 

We are looking for partners!

 If you have PayPal and you are ready to earn in our team - contact us: [email protected] 

Copyright © 2011-2024 Buy-Pharm, Inc. All rights reserved.